Traws Begin Period Cash Flow vs Free Cash Flow Yield Analysis

TRAW Stock

5.02 0.31 5.82%

Traws Pharma financial indicator trend analysis is much more than just breaking down Traws Pharma prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Traws Pharma is a good investment. Please check the relationship between Traws Pharma Begin Period Cash Flow and its Free Cash Flow Yield accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Traws Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Traws Stock please use our How to Invest in Traws Pharma guide.

Begin Period Cash Flow vs Free Cash Flow Yield

Begin Period Cash Flow vs Free Cash Flow Yield Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Traws Pharma Begin Period Cash Flow account and Free Cash Flow Yield. At this time, the significance of the direction appears to have very week relationship.

The correlation between Traws Pharma's Begin Period Cash Flow and Free Cash Flow Yield is 0.23. Overlapping area represents the amount of variation of Begin Period Cash Flow that can explain the historical movement of Free Cash Flow Yield in the same time period over historical financial statements of Traws Pharma, assuming nothing else is changed. The correlation between historical values of Traws Pharma's Begin Period Cash Flow and Free Cash Flow Yield is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Begin Period Cash Flow of Traws Pharma are associated (or correlated) with its Free Cash Flow Yield. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow Yield has no effect on the direction of Begin Period Cash Flow i.e., Traws Pharma's Begin Period Cash Flow and Free Cash Flow Yield go up and down completely randomly.

Correlation Coefficient

0.23

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Most indicators from Traws Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Traws Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Traws Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Traws Stock please use our How to Invest in Traws Pharma guide.At this time, Traws Pharma's Selling General Administrative is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to climb to 42.25 in 2024, whereas Enterprise Value Over EBITDA is likely to drop (20.38) in 2024.

	2020	2023	2024 (projected)
Total Revenue	231K	203.4K	193.2K
Depreciation And Amortization	13K	16K	15.6K

Total Revenue Depreciation And Amortization

Traws Pharma fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Inventory	Net Invested Capital	Property Plant And Equipment Gross	Capital Stock
Total Assets		-0.53	-0.81	0.93	-0.51	-0.16	-0.94	-0.49	-0.72	1.0	-0.69	-0.72	-0.16	1.0	-0.57	0.6	-0.55	-0.1	0.69	-0.85	1.0	-0.55	-0.3	0.98	0.04	0.73
Other Current Liab	-0.53		0.79	-0.4	0.48	0.53	0.37	0.42	0.21	-0.52	0.55	0.55	0.53	-0.52	0.16	-0.23	0.55	-0.4	-0.48	0.83	-0.53	0.05	-0.24	-0.46	-0.49	-0.55
Total Current Liabilities	-0.81	0.79		-0.67	0.27	0.29	0.67	0.29	0.68	-0.81	0.45	0.46	0.29	-0.81	0.15	-0.18	0.38	0.01	-0.43	0.94	-0.81	0.1	0.35	-0.7	-0.04	-0.47
Total Stockholder Equity	0.93	-0.4	-0.67		-0.38	0.16	-1.0	-0.25	-0.8	0.94	-0.53	-0.56	0.16	0.94	-0.44	0.48	-0.34	-0.35	0.5	-0.66	0.93	-0.42	-0.36	0.94	-0.16	0.59
Property Plant And Equipment Net	-0.51	0.48	0.27	-0.38		0.63	0.37	0.91	-0.16	-0.49	0.97	0.96	0.63	-0.49	0.83	-0.9	0.96	-0.61	-0.92	0.57	-0.52	0.75	-0.58	-0.58	-0.73	-0.95
Current Deferred Revenue	-0.16	0.53	0.29	0.16	0.63		-0.17	0.83	-0.46	-0.14	0.65	0.63	1.0	-0.14	0.53	-0.52	0.79	-0.94	-0.69	0.53	-0.16	0.47	-0.6	-0.14	-0.89	-0.6
Net Debt	-0.94	0.37	0.67	-1.0	0.37	-0.17		0.25	0.81	-0.94	0.52	0.56	-0.17	-0.94	0.45	-0.48	0.33	0.37	-0.5	0.66	-0.94	0.44	0.39	-0.95	0.18	-0.58
Retained Earnings	-0.49	0.42	0.29	-0.25	0.91	0.83	0.25		-0.25	-0.47	0.93	0.92	0.83	-0.47	0.89	-0.9	0.98	-0.76	-0.96	0.6	-0.49	0.84	-0.54	-0.54	-0.81	-0.91
Accounts Payable	-0.72	0.21	0.68	-0.8	-0.16	-0.46	0.81	-0.25		-0.73	0.01	0.05	-0.46	-0.73	-0.09	0.07	-0.17	0.72	0.01	0.48	-0.71	-0.07	0.82	-0.65	0.63	-0.07
Cash	1.0	-0.52	-0.81	0.94	-0.49	-0.14	-0.94	-0.47	-0.73		-0.67	-0.7	-0.14	1.0	-0.56	0.58	-0.53	-0.12	0.67	-0.85	1.0	-0.54	-0.32	0.98	0.02	0.72
Non Current Assets Total	-0.69	0.55	0.45	-0.53	0.97	0.65	0.52	0.93	0.01	-0.67		1.0	0.65	-0.67	0.88	-0.93	0.97	-0.56	-0.98	0.72	-0.69	0.81	-0.43	-0.74	-0.68	-1.0
Non Currrent Assets Other	-0.72	0.55	0.46	-0.56	0.96	0.63	0.56	0.92	0.05	-0.7	1.0		0.63	-0.7	0.88	-0.93	0.97	-0.53	-0.98	0.73	-0.72	0.82	-0.41	-0.77	-0.66	-1.0
Other Assets	-0.16	0.53	0.29	0.16	0.63	1.0	-0.17	0.83	-0.46	-0.14	0.65	0.63		-0.14	0.53	-0.52	0.79	-0.94	-0.69	0.53	-0.16	0.47	-0.6	-0.14	-0.89	-0.6
Cash And Short Term Investments	1.0	-0.52	-0.81	0.94	-0.49	-0.14	-0.94	-0.47	-0.73	1.0	-0.67	-0.7	-0.14		-0.56	0.58	-0.53	-0.12	0.67	-0.85	1.0	-0.54	-0.32	0.98	0.02	0.72
Net Receivables	-0.57	0.16	0.15	-0.44	0.83	0.53	0.45	0.89	-0.09	-0.56	0.88	0.88	0.53	-0.56		-0.98	0.85	-0.49	-0.93	0.44	-0.57	0.99	-0.4	-0.67	-0.6	-0.88
Common Stock Shares Outstanding	0.6	-0.23	-0.18	0.48	-0.9	-0.52	-0.48	-0.9	0.07	0.58	-0.93	-0.93	-0.52	0.58	-0.98		-0.89	0.48	0.95	-0.48	0.6	-0.96	0.43	0.7	0.6	0.93
Non Current Liabilities Total	-0.55	0.55	0.38	-0.34	0.96	0.79	0.33	0.98	-0.17	-0.53	0.97	0.97	0.79	-0.53	0.85	-0.89		-0.72	-0.97	0.68	-0.55	0.78	-0.56	-0.59	-0.8	-0.96
Other Current Assets	-0.1	-0.4	0.01	-0.35	-0.61	-0.94	0.37	-0.76	0.72	-0.12	-0.56	-0.53	-0.94	-0.12	-0.49	0.48	-0.72		0.58	-0.26	-0.09	-0.42	0.83	-0.07	0.97	0.51
Other Stockholder Equity	0.69	-0.48	-0.43	0.5	-0.92	-0.69	-0.5	-0.96	0.01	0.67	-0.98	-0.98	-0.69	0.67	-0.93	0.95	-0.97	0.58		-0.7	0.69	-0.88	0.4	0.74	0.68	0.98
Total Liab	-0.85	0.83	0.94	-0.66	0.57	0.53	0.66	0.6	0.48	-0.85	0.72	0.73	0.53	-0.85	0.44	-0.48	0.68	-0.26	-0.7		-0.85	0.37	0.07	-0.78	-0.33	-0.73
Total Current Assets	1.0	-0.53	-0.81	0.93	-0.52	-0.16	-0.94	-0.49	-0.71	1.0	-0.69	-0.72	-0.16	1.0	-0.57	0.6	-0.55	-0.09	0.69	-0.85		-0.55	-0.29	0.98	0.05	0.73
Common Stock	-0.55	0.05	0.1	-0.42	0.75	0.47	0.44	0.84	-0.07	-0.54	0.81	0.82	0.47	-0.54	0.99	-0.96	0.78	-0.42	-0.88	0.37	-0.55		-0.32	-0.65	-0.51	-0.82
Inventory	-0.3	-0.24	0.35	-0.36	-0.58	-0.6	0.39	-0.54	0.82	-0.32	-0.43	-0.41	-0.6	-0.32	-0.4	0.43	-0.56	0.83	0.4	0.07	-0.29	-0.32		-0.2	0.88	0.4
Net Invested Capital	0.98	-0.46	-0.7	0.94	-0.58	-0.14	-0.95	-0.54	-0.65	0.98	-0.74	-0.77	-0.14	0.98	-0.67	0.7	-0.59	-0.07	0.74	-0.78	0.98	-0.65	-0.2		0.09	0.79
Property Plant And Equipment Gross	0.04	-0.49	-0.04	-0.16	-0.73	-0.89	0.18	-0.81	0.63	0.02	-0.68	-0.66	-0.89	0.02	-0.6	0.6	-0.8	0.97	0.68	-0.33	0.05	-0.51	0.88	0.09		0.64
Capital Stock	0.73	-0.55	-0.47	0.59	-0.95	-0.6	-0.58	-0.91	-0.07	0.72	-1.0	-1.0	-0.6	0.72	-0.88	0.93	-0.96	0.51	0.98	-0.73	0.73	-0.82	0.4	0.79	0.64

Click cells to compare fundamentals

Traws Pharma Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Traws Stock Analysis

When running Traws Pharma's price analysis, check to measure Traws Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Traws Pharma is operating at the current time. Most of Traws Pharma's value examination focuses on studying past and present price action to predict the probability of Traws Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Traws Pharma's price. Additionally, you may evaluate how the addition of Traws Pharma to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Traws Begin Period Cash Flow vs Free Cash Flow Yield Analysis

Begin Period Cash Flow vs Free Cash Flow Yield

Begin Period Cash Flow vs Free Cash Flow Yield Correlation Analysis

Correlation Coefficient

Begin Period Cash Flow

Free Cash Flow Yield

Traws Pharma fundamental ratios Correlations

Traws Pharma Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for Traws Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Other Assets	+ 1.0	Current Deferred Revenue
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash

Capital Stock	- 1.0	Non Currrent Assets Other
Capital Stock	- 1.0	Non Current Assets Total
Net Debt	- 1.0	Total Stockholder Equity
Common Stock Shares Outstanding	- 0.98	Net Receivables
Other Stockholder Equity	- 0.98	Non Currrent Assets Other
Other Stockholder Equity	- 0.98	Non Current Assets Total